Day 3: Wednesday, March 5, 2025Wednesday, 5 March 2025 - ET (Eastern Time, GMT-05:00)

Ask your burning questions to an executive sales representative at a major organization who is taking a year in a compliance rotation.

• How to foster open communication and learning between sales team and compliance, operations and marketing

• What challenges are reps facing and what they wish you knew

• Time involved from start to finish in planning a live program, size of territory traveled in a car, finding compliant ways to recruit

Join our interactive forum to explore the differences between medical device and pharmaceutical speaker programs with a focus on speaker training, educational needs, and HCP engagement. Engage in live polling and open discussion to uncover actionable insights and strategies:

• Participate in a forum to discuss handling medical device and procedural training versus traditional pharma approaches

• Understand how needs assessments differ and discuss best practices for addressing them in each sector

• Share strategies for optimizing HCP engagement and selecting vendors for medical device programs

• Explore ways to maximize attendance, speaker utilization, and tailor unique program types to diverse attendee profiles

• Dive into the key expectations of KOLs regarding travel, experience, reimbursement, and the perceived value of their time

• Success and Challenges: Explore what has been effective and what hasn't in managing HCP schedules and commitments, including timelines, logistics, training, and documentation

• Uncover the non-monetary motivations driving HCP participation in speaker programs and how these can be leveraged to foster engagement

• Discuss best practices for aligning speaker program design with KOL preferences to improve satisfaction and program effectiveness

• Identify the key qualifications, expertise, and characteristics that align with your organization's goals and compliance requirements to ensure you recruit speakers who resonate with your target audience

• Determine the ideal bureau size by balancing diverse expertise with logistical and financial considerations, ensuring that your bureau remains agile and effective

• Develop a systematic approach to attracting top talent, including leveraging existing networks, offering competitive incentives, and providing ongoing support to maintain a dynamic and engaged speaker roster

• Understand the unique considerations for planning speaker programs focused on rare diseases, including tailoring content to specialized audiences and addressing their distinct educational needs

• Explore the specific regulatory and compliance considerations for rare disease programs, including documentation, disclosure requirements, and ensuring adherence to industry guidelines

• Discuss best practices for organizing and executing rare disease speaker programs, from engaging key opinion leaders to managing logistical complexities and optimizing program impact